ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection

This study is currently recruiting participants.
Verified by Johns Hopkins University, December 2007

Sponsored by: Johns Hopkins University
Information provided by: Johns Hopkins University
ClinicalTrials.gov Identifier: NCT00583466
  Purpose

For removal of large flat lesions of the gastro-intestinal tract injection of a solution under the lesion creates a "safety" cushion and protects from damage to the gastrointestinal tract wall. Various solutions are currently used, but some of them are easy to inject but quickly dissipate (normal saline),other solutions are more longer lasting (hydroxypropyl methylcellulose, hyaluronic acid, etc) but are very difficult to inject and can be expensive and not always available. We decided to use blood drawn from the patient for injection under the lesion. We performed previously animal experiments which demonstrated that blood is easy to inject and creates a protective cushion which lasts longer than other fluids which are currently used for protective cushion creation.


Condition Intervention Phase
Large Polyps in the Gastrointestinal Tract
Drug: Autologous blood injection
Drug: Normal saline
Drug: HPMC
Phase II

MedlinePlus related topics:   Endoscopy   

Drug Information available for:   Sodium chloride    Methylcellulose   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection

Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:
  • Duration of the submucosal cushion Ease of injection Ability to complete lesion removal Post-procedure complications [ Time Frame: Immediately after the procedure ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Ability to perform lesion removal Ability to visualize during the procedure [ Time Frame: Immediately after the procedure ] [ Designated as safety issue: Yes ]

Estimated Enrollment:   18
Study Start Date:   May 2007
Estimated Study Completion Date:   May 2008
Estimated Primary Completion Date:   May 2008 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1 Normal saline arm: Active Comparator
Polypectomy with normal saline injected for submucosal cushion creation
Drug: Normal saline
Normal saline will be injected under the lesion to create submucosal cushion
2 HPMC arm: Active Comparator
Polypectomy after injection of hydroxypropyl methylcellulose (HPMC) to create submucosal cushion
Drug: HPMC
Hydroxypropyl methylcellulose (HPMC) will be injected under the lesion to create submucosal cushion
3 Blood arm: Experimental
Polypectomy after injection of autologous blood
Drug: Autologous blood injection
Autologous blood will be drawn from the patient and then reinjected under the lesion to create a safety cushion

Detailed Description:

For removal of large flat lesions of the gastro-intestinal tract injection of a solution under the lesion creates a "safety" cushion and protects from damage to the gastrointestinal tract wall. Various solutions are currently used, but some of them are easy to inject but quickly dissipate (normal saline),other solutions are more longer lasting (hydroxypropyl methylcellulose, hyaluronic acid, etc) but are very difficult to inject and can be expensive and not always available. We decided to use blood drawn from the patient for injection under the lesion. We performed previously animal experiments which demonstrated that blood is easy to inject and creates a protective cushion which lasts longer than other fluids which are currently used for protective cushion creation. Blood can also have local hemostatic action preventing from bleeding during polypectomy.

  Eligibility
Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Polyps equal or larger than 1 cm

Exclusion Criteria:

  • Coagulopathy
  • Inability to sign informed consent
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00583466

Contacts
Contact: Sergey V Kantsevoy, M.D., Ph.D     410-614-6708     svkan@jhmi.edu    
Contact: Samuel A Giday, M.D.     410-614-6708     sgiday1@jhmi.edu    

Locations
United States, Maryland
Johns Hopkins Hospital     Recruiting
      Baltimore, Maryland, United States, 21205
      Contact: Sergey V. Kantsevoy, M.D., Ph.D.     410-614-6708     svkan@jhmi.edu    
      Contact: Samuel A. Giday, M.D.     410-614-6708     sgiday1@jhmi.edu    

Sponsors and Collaborators
Johns Hopkins University

Investigators
Principal Investigator:     Sergey V. Kantsevoy, M.D., Ph.D.     Johns Hopkins University    
  More Information


Publications:

Responsible Party:   Johns Hopkins University School of Medicine ( Sergey V. Kantsevoy, M.D., Ph.D., Associate Professor of Medicine )
Study ID Numbers:   NA_00008376
First Received:   December 20, 2007
Last Updated:   December 20, 2007
ClinicalTrials.gov Identifier:   NCT00583466
Health Authority:   United States: Institutional Review Board

Keywords provided by Johns Hopkins University:
submucosal cushion  
polypectomy  
endoscopic mucosal resection  

Study placed in the following topic categories:
Polyps

ClinicalTrials.gov processed this record on October 31, 2008




Links to all studies - primarily for crawlers